Related references
Note: Only part of the references are listed.Enhancer transcription: what, where, when, and why?
Nathaniel D. Tippens et al.
GENES & DEVELOPMENT (2018)
The circadian clock regulates cisplatin-induced toxicity and tumor regression in melanoma mouse and human models
Panshak P. Dakup et al.
Oncotarget (2018)
Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence
Gabriele Sulli et al.
NATURE (2018)
Transcriptional architecture of the mammalian circadian clock
Joseph S. Takahashi
NATURE REVIEWS GENETICS (2017)
The punctilious RNA polymerase II core promoter
Long Vo Ngoc et al.
GENES & DEVELOPMENT (2017)
Diurnal regulation of RNA polymerase III transcription is under the control of both the feeding-fasting response and the circadian clock
Francois Mange et al.
GENOME RESEARCH (2017)
Molecular mechanisms and genomic maps of DNA excision repair in Escherichia coli and humans
Jinchuan Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma
Emily A. Slat et al.
JOURNAL OF BIOLOGICAL RHYTHMS (2017)
Time-Restricted Feeding Shifts the Skin Circadian Clock and Alters UVB-Induced DNA Damage
Hong Wang et al.
CELL REPORTS (2017)
Enhancing circadian clock function in cancer cells inhibits tumor growth
Silke Kiessling et al.
BMC BIOLOGY (2017)
Nuclear Proteomics Uncovers Diurnal Regulatory Landscapes in Mouse Liver
Jingkui Wang et al.
CELL METABOLISM (2017)
Mechanisms of DNA Repair by Photolyase and Excision Nuclease (Nobel Lecture)
Aziz Sancar
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
MetaCycle: an integrated R package to evaluate periodicity in large scale data
Gang Wu et al.
BIOINFORMATICS (2016)
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Timothy C. Johnstone et al.
CHEMICAL REVIEWS (2016)
Mammalian Period represses and de-represses transcription by displacing CLOCK-BMAL1 from promoters in a Cryptochrome-dependent manner
Yi-Ying Chiou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Cisplatin DNA damage and repair maps of the human genome at single-nucleotide resolution
Jinchuan Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Cancer Clocks Out for Lunch: Disruption of Circadian Rhythm and Metabolic Oscillation in Cancer
Brian J. Altman
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Genome-wide analysis of human global and transcription-coupled excision repair of UV damage at single-nucleotide resolution
Jinchuan Hu et al.
GENES & DEVELOPMENT (2015)
Circadian Clock, Cancer, and Chemotherapy
Aziz Sancar et al.
BIOCHEMISTRY (2015)
Daily rhythms are retained both in spontaneously developed sarcomas and in xenografts grown in immunocompromised SCID mice
Maria Comas et al.
CHRONOBIOLOGY INTERNATIONAL (2014)
A circadian gene expression atlas in mammals: Implications for biology and medicine
Ray Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Molecular architecture of the mammalian circadian clock
Carrie L. Partch et al.
TRENDS IN CELL BIOLOGY (2014)
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
Helga Thorvaldsdottir et al.
BRIEFINGS IN BIOINFORMATICS (2013)
Nucleotide Excision Repair in Human Cells FATE OF THE EXCISED OLIGONUCLEOTIDE CARRYING DNA DAMAGE IN VIVO
Jinchuan Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Transcriptional Architecture and Chromatin Landscape of the Core Circadian Clock in Mammals
Nobuya Koike et al.
SCIENCE (2012)
Nascent-Seq reveals novel features of mouse circadian transcriptional regulation
Jerome S. Menet et al.
ELIFE (2012)
Disrupting the circadian clock: Gene-specific effects on aging, cancer, and other phenotypes
Elizabeth A. Yu et al.
AGING-US (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Control of skin cancer by the circadian rhythm
Shobhan Gaddameedhi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Role of Clock Genes in Pharmacology
Georgios K. Paschos et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Circadian Timing in Cancer Treatments
Francis Levi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
BEDTools: a flexible suite of utilities for comparing genomic features
Aaron R. Quinlan et al.
BIOINFORMATICS (2010)
Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
Tae-Hong Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Harmonics of Circadian Gene Transcription in Mammals
Michael E. Hughes et al.
PLOS GENETICS (2009)
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy
Matthew D. Hall et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Transcription-coupled DNA repair: two decades of progress and surprises
Philip C. Hanawalt et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Circadian rhythms: Mechanisms and therapeutic implications
Francis Levi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2007)
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer:: The European Organisation for Research and Treatment of Cancer Chronotherapy group
Sylvie Giacchetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effects of light and food schedules on liver and tumor molecular clocks in mice
E Filipski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Effects of chronic jet lag on tumor progression in mice
E Filipski et al.
CANCER RESEARCH (2004)
Randomized phase III trial of standard timed doxorubicin plus cisplatin versus circadian timed doxorubicin plus cisplatin in stage III and IV or recurrent endometrial carcinoma: A Gynecologic Oncology Group Study
HH Gallion et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)